18 Years Factory (R)-1-Phenylpropan-1-Amine - (1R,2S)-(+)-1-Amino-2-indanol CAS 136030-00-7 Purity ≥98.0% (HPLC) E.E. ≥98.0% Indinavir Sulfate Intermediate – Ruifu
18 Years Factory (R)-1-Phenylpropan-1-Amine - (1R,2S)-(+)-1-Amino-2-indanol CAS 136030-00-7 Purity ≥98.0% (HPLC) E.E. ≥98.0% Indinavir Sulfate Intermediate – Ruifu Detail:
Manufacturer with High Quality and Competitive Price
Commercial Supply Indinavir Sulfate (CAS: 157810-81-6) Related Intermediates:
(1R,2S)-(+)-1-Amino-2-indanol CAS: 136030-00-7
(1S,2R)-(-)-1-Amino-2-indanol CAS: 126456-43-7
Chemical Name | (1R,2S)-(+)-1-Amino-2-indanol |
Synonyms | (1R,2S)-(+)-1-Amino-2-hydroxyindan |
CAS Number | 136030-00-7 |
CAT Number | RF-CC119 |
Stock Status | In Stock, Production Scale Up to Tons |
Molecular Formula | C9H11NO |
Molecular Weight | 149.19 |
Store Under Inert Gas | Store Under Inert Gas |
Condition to Avoid | Air Sensitive |
Brand | Ruifu Chemical |
Item | Specifications |
Appearance | White Crystalline Powder |
Melting Point | 117.0~121.0℃ |
Loss on Drying | ≤0.50% |
E.E. | ≥98.0% |
Purity / Analysis Method | ≥98.0% (HPLC) |
Test Standard | Enterprise Standard |
Usage | Indinavir Sulfate (CAS: 157810-81-6) Intermediate |
Package: Bottle, Cardboard Drum, 25kg/Drum, or according to customer’s requirement.
Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.
Manufacturer with High Quality and Competitive Price
Commercial Supply Indinavir Sulfate (CAS: 157810-81-6) Related Intermediates:
(1R,2S)-(+)-1-Amino-2-indanol CAS: 136030-00-7
(1S,2R)-(-)-1-Amino-2-indanol CAS: 126456-43-7
The Indinavir Sulfate (CAS: 157810-81-6) is an organic compound with the formula C36H47N5O4.H2SO4. The chemical name is (2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-5-[[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-5-oxopentyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide; sulfuric acid. With the CAS registry number 157810-81-6. The product’s categories are Active Pharmaceutical Ingredients; Anti-viral Compounds; Anti-virals; Inhibitors; Intermediates & Fine Chemicals; Non-nucleoside Reverse Transcriptase; Pharmaceuticals; Indinavir. Besides, it is a protease inhibitor used as a component of highly active antiretroviral therapy (HAART) to treat HIV infection and AIDS.
Indinavir(MK-639) is a protease inhibitor used as a component of highly active antiretroviral therapy (HAART) to treat HIV infection and AIDS.MK-639 appears to have significant dose-related antiviral activity and is well tolerated.
Indinavir (Crixivan) is a potent inhibitor of HIV reverse transcriptase. It produces the side effects common to all protease inhibitors and also may produce nephrolithiasis, urolithiasis, and possibly renal insufficiency or renal failure. This problem occurs more frequently in children (approximately 30%) than adults (approximately 10%) and can be minimized by drinking at least 1.5 L of water daily. Additional side effects include asymptomatic hyperbilirubinemia, alopecia, ingrown toenails, and paronychia. Hemolytic anemia rarely occurs. Rifampin should not be given with indinavir.
Product detail pictures:
Related Product Guide:
Dedicated to strict high-quality management and considerate purchaser support, our experienced employees members are usually available to discuss your specifications and be certain full shopper satisfaction for 18 Years Factory (R)-1-Phenylpropan-1-Amine - (1R,2S)-(+)-1-Amino-2-indanol CAS 136030-00-7 Purity ≥98.0% (HPLC) E.E. ≥98.0% Indinavir Sulfate Intermediate – Ruifu , The product will supply to all over the world, such as: Tunisia, Provence, New York, We've customers from more than 20 countries and our reputation has been recognized by our esteemed customers. Never-ending improvement and striving for 0% deficiency are our two main quality policies. Ought to you want anything, don't hesitate to contact us.
By Jason from Hamburg - 2017.06.16 18:23
It is really lucky to meet such a good supplier, this is our most satisfied cooperation, I think we will work again!
By Roberta from Finland - 2017.07.07 13:00